Global Bile Duct Cancer Market Research Report 2023

Bile duct cancer or cholangiocarcinoma is a form of cancer in which epithelial cells are mutated, i.e., they show epithelial differentiation in the bile duct. It is a type of rare neoplasm.

The global Bile Duct Cancer market was valued at US$ 174.3 million in 2022 and is anticipated to reach US$ 261.5 million by 2029, witnessing a CAGR of 7.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Bile Duct Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Bile Duct Cancer is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Bile Duct Cancer in Hospitals & Clinics is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Bile Duct Cancer include Pfizer, F. Hoffmann-La Roche, Bristol-Myers Squibb, Teva Pharmaceutical, Eli Lilly and Company, Sanofi, Fresenius Kabi and Mylan, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Bile Duct Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bile Duct Cancer.

The Bile Duct Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bile Duct Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bile Duct Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bile Duct Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 5-fluorouracil

1.2.3 Gemcitabine

1.2.4 Cisplatin

1.2.5 Other

1.3 Market by Application

1.3.1 Global Bile Duct Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals & Clinics

1.3.3 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Bile Duct Cancer Market Perspective (2018-2029)

2.2 Bile Duct Cancer Growth Trends by Region

2.2.1 Global Bile Duct Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Bile Duct Cancer Historic Market Size by Region (2018-2023)

2.2.3 Bile Duct Cancer Forecasted Market Size by Region (2024-2029)

2.3 Bile Duct Cancer Market Dynamics

2.3.1 Bile Duct Cancer Industry Trends

2.3.2 Bile Duct Cancer Market Drivers

2.3.3 Bile Duct Cancer Market Challenges

2.3.4 Bile Duct Cancer Market Restraints

3.1 Global Top Bile Duct Cancer Players by Revenue

3.1.1 Global Top Bile Duct Cancer Players by Revenue (2018-2023)

3.1.2 Global Bile Duct Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Bile Duct Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Bile Duct Cancer Revenue

3.4 Global Bile Duct Cancer Market Concentration Ratio

3.4.1 Global Bile Duct Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bile Duct Cancer Revenue in 2022

3.5 Bile Duct Cancer Key Players Head office and Area Served

3.6 Key Players Bile Duct Cancer Product Solution and Service

3.7 Date of Enter into Bile Duct Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Bile Duct Cancer Historic Market Size by Type (2018-2023)

4.2 Global Bile Duct Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Bile Duct Cancer Historic Market Size by Application (2018-2023)

5.2 Global Bile Duct Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Bile Duct Cancer Market Size (2018-2029)

6.2 North America Bile Duct Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Bile Duct Cancer Market Size by Country (2018-2023)

6.4 North America Bile Duct Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Bile Duct Cancer Market Size (2018-2029)

7.2 Europe Bile Duct Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Bile Duct Cancer Market Size by Country (2018-2023)

7.4 Europe Bile Duct Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Bile Duct Cancer Market Size (2018-2029)

8.2 Asia-Pacific Bile Duct Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Bile Duct Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Bile Duct Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Bile Duct Cancer Market Size (2018-2029)

9.2 Latin America Bile Duct Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Bile Duct Cancer Market Size by Country (2018-2023)

9.4 Latin America Bile Duct Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Bile Duct Cancer Market Size (2018-2029)

10.2 Middle East & Africa Bile Duct Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Bile Duct Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Bile Duct Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Bile Duct Cancer Introduction

11.1.4 Pfizer Revenue in Bile Duct Cancer Business (2018-2023)

11.1.5 Pfizer Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Detail

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Bile Duct Cancer Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2018-2023)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Detail

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Bile Duct Cancer Introduction

11.3.4 Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2018-2023)

11.3.5 Bristol-Myers Squibb Recent Development

11.4 Teva Pharmaceutical

11.4.1 Teva Pharmaceutical Company Detail

11.4.2 Teva Pharmaceutical Business Overview

11.4.3 Teva Pharmaceutical Bile Duct Cancer Introduction

11.4.4 Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2018-2023)

11.4.5 Teva Pharmaceutical Recent Development

11.5 Eli Lilly and Company

11.5.1 Eli Lilly and Company Company Detail

11.5.2 Eli Lilly and Company Business Overview

11.5.3 Eli Lilly and Company Bile Duct Cancer Introduction

11.5.4 Eli Lilly and Company Revenue in Bile Duct Cancer Business (2018-2023)

11.5.5 Eli Lilly and Company Recent Development

11.6 Sanofi

11.6.1 Sanofi Company Detail

11.6.2 Sanofi Business Overview

11.6.3 Sanofi Bile Duct Cancer Introduction

11.6.4 Sanofi Revenue in Bile Duct Cancer Business (2018-2023)

11.6.5 Sanofi Recent Development

11.7 Fresenius Kabi

11.7.1 Fresenius Kabi Company Detail

11.7.2 Fresenius Kabi Business Overview

11.7.3 Fresenius Kabi Bile Duct Cancer Introduction

11.7.4 Fresenius Kabi Revenue in Bile Duct Cancer Business (2018-2023)

11.7.5 Fresenius Kabi Recent Development

11.8 Mylan

11.8.1 Mylan Company Detail

11.8.2 Mylan Business Overview

11.8.3 Mylan Bile Duct Cancer Introduction

11.8.4 Mylan Revenue in Bile Duct Cancer Business (2018-2023)

11.8.5 Mylan Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Bile Duct Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of 5-fluorouracil

    Table 3. Key Players of Gemcitabine

    Table 4. Key Players of Cisplatin

    Table 5. Key Players of Other

    Table 6. Global Bile Duct Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Bile Duct Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Bile Duct Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Bile Duct Cancer Market Share by Region (2018-2023)

    Table 10. Global Bile Duct Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Bile Duct Cancer Market Share by Region (2024-2029)

    Table 12. Bile Duct Cancer Market Trends

    Table 13. Bile Duct Cancer Market Drivers

    Table 14. Bile Duct Cancer Market Challenges

    Table 15. Bile Duct Cancer Market Restraints

    Table 16. Global Bile Duct Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Bile Duct Cancer Market Share by Players (2018-2023)

    Table 18. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer as of 2022)

    Table 19. Ranking of Global Top Bile Duct Cancer Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Bile Duct Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Bile Duct Cancer Product Solution and Service

    Table 23. Date of Enter into Bile Duct Cancer Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Bile Duct Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Bile Duct Cancer Revenue Market Share by Type (2018-2023)

    Table 27. Global Bile Duct Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Bile Duct Cancer Revenue Market Share by Type (2024-2029)

    Table 29. Global Bile Duct Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Bile Duct Cancer Revenue Market Share by Application (2018-2023)

    Table 31. Global Bile Duct Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Bile Duct Cancer Revenue Market Share by Application (2024-2029)

    Table 33. North America Bile Duct Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Bile Duct Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Bile Duct Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Bile Duct Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Bile Duct Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Bile Duct Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Bile Duct Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Bile Duct Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Bile Duct Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Bile Duct Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Bile Duct Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Bile Duct Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Bile Duct Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Bile Duct Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Bile Duct Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Pfizer Company Detail

    Table 49. Pfizer Business Overview

    Table 50. Pfizer Bile Duct Cancer Product

    Table 51. Pfizer Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 52. Pfizer Recent Development

    Table 53. F. Hoffmann-La Roche Company Detail

    Table 54. F. Hoffmann-La Roche Business Overview

    Table 55. F. Hoffmann-La Roche Bile Duct Cancer Product

    Table 56. F. Hoffmann-La Roche Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 57. F. Hoffmann-La Roche Recent Development

    Table 58. Bristol-Myers Squibb Company Detail

    Table 59. Bristol-Myers Squibb Business Overview

    Table 60. Bristol-Myers Squibb Bile Duct Cancer Product

    Table 61. Bristol-Myers Squibb Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 62. Bristol-Myers Squibb Recent Development

    Table 63. Teva Pharmaceutical Company Detail

    Table 64. Teva Pharmaceutical Business Overview

    Table 65. Teva Pharmaceutical Bile Duct Cancer Product

    Table 66. Teva Pharmaceutical Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 67. Teva Pharmaceutical Recent Development

    Table 68. Eli Lilly and Company Company Detail

    Table 69. Eli Lilly and Company Business Overview

    Table 70. Eli Lilly and Company Bile Duct Cancer Product

    Table 71. Eli Lilly and Company Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 72. Eli Lilly and Company Recent Development

    Table 73. Sanofi Company Detail

    Table 74. Sanofi Business Overview

    Table 75. Sanofi Bile Duct Cancer Product

    Table 76. Sanofi Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 77. Sanofi Recent Development

    Table 78. Fresenius Kabi Company Detail

    Table 79. Fresenius Kabi Business Overview

    Table 80. Fresenius Kabi Bile Duct Cancer Product

    Table 81. Fresenius Kabi Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 82. Fresenius Kabi Recent Development

    Table 83. Mylan Company Detail

    Table 84. Mylan Business Overview

    Table 85. Mylan Bile Duct Cancer Product

    Table 86. Mylan Revenue in Bile Duct Cancer Business (2018-2023) & (US$ Million)

    Table 87. Mylan Recent Development

    Table 88. Research Programs/Design for This Report

    Table 89. Key Data Information from Secondary Sources

    Table 90. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Bile Duct Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Bile Duct Cancer Market Share by Type: 2022 VS 2029

    Figure 3. 5-fluorouracil Features

    Figure 4. Gemcitabine Features

    Figure 5. Cisplatin Features

    Figure 6. Other Features

    Figure 7. Global Bile Duct Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Bile Duct Cancer Market Share by Application: 2022 VS 2029

    Figure 9. Hospitals & Clinics Case Studies

    Figure 10. Other Case Studies

    Figure 11. Bile Duct Cancer Report Years Considered

    Figure 12. Global Bile Duct Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Bile Duct Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Bile Duct Cancer Market Share by Region: 2022 VS 2029

    Figure 15. Global Bile Duct Cancer Market Share by Players in 2022

    Figure 16. Global Top Bile Duct Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bile Duct Cancer as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Bile Duct Cancer Revenue in 2022

    Figure 18. North America Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Bile Duct Cancer Market Share by Country (2018-2029)

    Figure 20. United States Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Bile Duct Cancer Market Share by Country (2018-2029)

    Figure 24. Germany Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Bile Duct Cancer Market Share by Region (2018-2029)

    Figure 32. China Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Bile Duct Cancer Market Share by Country (2018-2029)

    Figure 40. Mexico Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Bile Duct Cancer Market Share by Country (2018-2029)

    Figure 44. Turkey Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Bile Duct Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Pfizer Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 48. Bristol-Myers Squibb Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 49. Teva Pharmaceutical Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 50. Eli Lilly and Company Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 51. Sanofi Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 52. Fresenius Kabi Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 53. Mylan Revenue Growth Rate in Bile Duct Cancer Business (2018-2023)

    Figure 54. Bottom-up and Top-down Approaches for This Report

    Figure 55. Data Triangulation

    Figure 56. Key Executives Interviewed